SHAWNEE, Kan. & SAN FRANCISCO–(BUSINESS WIRE)–Argenta, the global contract development, research and manufacturing organization (CDRMO) dedicated exclusively to animal health, and Loyal, the clinical-stage animal health company pioneering the first lifespan extension drugs for dogs, today announced a strategic partnership under which Argenta will support early-stage development of LOY-003, Loyal’s investigational candidate for large-breed dog lifespan extension. The collaboration will focus o

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.